Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin.
Moreno A, Bárcena R, García-Garzón S, Muriel A, Quereda C, Moreno L, Mateos ML, Fortún J, Martín-Dávila P, García M, Blesa C, Otón E, Moreno A, Moreno S. Moreno A, et al. Among authors: barcena r. J Hepatol. 2005 Nov;43(5):783-90. doi: 10.1016/j.jhep.2005.05.019. Epub 2005 Jun 21. J Hepatol. 2005. PMID: 16084622
Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.
Foruny JR, Blázquez J, Moreno A, Bárcena R, Gil-Grande L, Quereda C, Pérez-Elías MJ, Moreno J, Sánchez J, Muriel A, Rodriguez-Sagrado MA, Moreno S. Foruny JR, et al. Among authors: barcena r. Eur J Gastroenterol Hepatol. 2005 Nov;17(11):1157-64. doi: 10.1097/00042737-200511000-00002. Eur J Gastroenterol Hepatol. 2005. PMID: 16215426
Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization.
Foruny JR, Bárcena R, Moreno A, Blázquez J, Manzano R, Gil-Grande LA, Moreno A, Nuño J. Foruny JR, et al. Among authors: barcena r. Transplantation. 2006 Jul 27;82(2):289-90. doi: 10.1097/01.tp.0000226223.95971.e7. Transplantation. 2006. PMID: 16858295 No abstract available.
Partial splenic embolization and peg-IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long-term outcome.
Bárcena R, Moreno A, Foruny JR, Blázquez J, Graus J, Riesco JM, Blesa C, García-Hoz F, Sánchez J, Gil-Grande L, Nuño J, Fortún J, Rodriguez-Sagrado MA, Moreno A. Bárcena R, et al. Clin Transplant. 2010 May-Jun;24(3):366-74. doi: 10.1111/j.1399-0012.2009.01081.x. Epub 2009 Oct 22. Clin Transplant. 2010. PMID: 19863593
Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin.
Oton E, Barcena R, Moreno-Planas JM, Cuervas-Mons V, Moreno-Zamora A, Barrios C, Garcia-Garzon S, Moreno A, Boullosa-Graña E, Rubio-Gonzalez EE, Garcia-Gonzalez M, Blesa C, Mateos ML. Oton E, et al. Among authors: barcena r. Am J Transplant. 2006 Oct;6(10):2348-55. doi: 10.1111/j.1600-6143.2006.01470.x. Epub 2006 Jul 26. Am J Transplant. 2006. PMID: 16869810 Free article.
144 results